Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHMI-8B malaria sporozoite re-exposure study
NL-OMON33874Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2009
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of Plasmodium falciparum sporozoites and atovaquone + proguanil in Malaria (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Time to thick smear positivity, Quantitative parasitemia by PCR and 2 more. Started Nov 2009; status: active, not recruiting.
02
Drugs
Plasmodium falciparum sporozoitesatovaquone + proguanil
03
Conditions
Malaria
Beyond the preview
Go deeper on NL-OMON33874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33874.